Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hong Kong's Biosimilar Registration Requirements To Kick In From Jan. 1

This article was originally published in SRA

Executive Summary

Hong Kong's Pharmacy and Poisons Board has issued its first ever guidance1,2 on the evaluation and registration of biosimilar products, which will come into effect on Jan. 1, 2016.